Related Experiment Video
Updated: Feb 19, 2026
11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.7K
Viral hepatitis B: established and emerging therapies
1Fondazione A. Cesalpino, c/o I Clinica Medica, Policlinico Umberto I, Viale del Policlinico n. 155, 00161 Rome, Italy. clara.balsano@uniroma1.it
Current Medicinal Chemistry
|May 14, 2008
Summary
New antiviral therapies for chronic hepatitis B virus (HBV) infection are emerging, but drug resistance remains a challenge. Future treatments will likely involve combination therapy with new, potent antiviral drugs to improve patient outcomes.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic hepatitis B virus (HBV) infection can progress to cirrhosis and hepatocellular carcinoma (HCC).
- Outcomes depend on viral factors and host immune response, influencing viral persistence.
- Current treatment strategies for hepatitis B require further definition regarding efficacy, duration, and criteria for initiation or modification.
Purpose of the Study:
- To review new and developing treatment options for HBV-associated liver diseases.
- To address challenges in managing chronic HBV infection and its complications.
- To discuss the evolving landscape of hepatitis B therapeutics.
Main Methods:
- Review of current literature on hepatitis B treatments.
- Analysis of immunomodulatory and antiviral therapies.
- Discussion of drug resistance mechanisms and implications.
Main Results:
- Existing therapies include interferons and nucleoside/nucleotide analogues, each with limitations.
- Antiviral drug resistance is a significant problem, leading to poorer patient prognosis.
- Newer, stronger antiviral drugs are under development.
Conclusions:
- Optimal management strategies for chronic hepatitis B require further research.
- Combination therapy and long-term use of novel antiviral drugs are promising future options.
- Future treatments must balance efficacy with safety, low resistance rates, and affordability.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
01:29Subviral Agents
623
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
623
01:29Viruses with RNA Genomes
1.0K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.0K
01:10Retrovirus Life Cycles
49.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.9K
01:26Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K